Tocotrienols: The Emerging Face of Natural Vitamin E

Vitamins and Hormones

Volumn 76, Issue , 2007, Pages 203-261

  Sen, Chandan K ^a   Khanna, Savita ^a   Rink, Cameron ^a   Roy, Sashwati ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ANTIOXIDANT; DRUG DERIVATIVE;

ANIMAL; CHEMISTRY; HUMAN; PHYSIOLOGY; REVIEW;

ANIMALS; ANTIOXIDANTS; HUMANS; TOCOTRIENOLS; VITAMIN E;

EID: 34347390404     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(07)76008-9     Document Type: Review

References (250)

1. Adachi H., and Ishii N. Effects of tocotrienols on life span and protein carbonylation in Caenorhabditis elegans. J. Gerontol. A Biol. Sci. Med. Sci. 55 (2000) B280-B285
2. Adachi K., Miki M., Tamai H., Tokuda M., and Mino M. Adipose tissues and vitamin E. J. Nutr. Sci. Vitaminol. (Tokyo) 36 (1990) 327-337
3. Adesuyi S.A., Cockrell C.S., Gamache D.A., and Ellis E.F. Lipoxygenase metabolism of arachidonic acid in brain. J. Neurochem. 45 (1985) 770-776
4. Agarwal M.K., Agarwal M.L., Athar M., and Gupta S. Tocotrienol-rich fraction of palm oil activates p53, modulates Bax/Bcl2 ratio and induces apoptosis independent of cell cycle association. Cell Cycle 3 (2004) 205-211
5. Ahmad N.S., Khalid B.A., Luke D.A., and Ima Nirwana S. Tocotrienol offers better protection than tocopherol from free radical-induced damage of rat bone. Clin. Exp. Pharmacol. Physiol. 32 (2005) 761-770
6. Aikawa R., Komuro I., Yamazaki T., Zou Y., Kudoh S., Tanaka M., Shiojima I., Hiroi Y., and Yazaki Y. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J. Clin. Invest. 100 (1997) 1813-1821
7. Alper O., and Bowden E.T. Novel insights into c-Src. Curr. Pharm. Des. 11 (2005) 1119-1130
8. Anderson S.L., and Rubin B.Y. Tocotrienols reverse IKAP and monoamine oxidase deficiencies in familial dysautonomia. Biochem. Biophys. Res. Commun. 336 (2005) 150-156
9. Anderson S.L., Qiu J., and Rubin B.Y. Tocotrienols induce IKBKAP expression: A possible therapy for familial dysautonomia. Biochem. Biophys. Res. Commun. 306 (2003) 303-309
10. Araya H., Tomita M., and Hayashi M. The novel formulation design of self-emulsifying drug delivery systems (SEDDS) type O/W microemulsion III: The permeation mechanism of a poorly water soluble drug entrapped O/W microemulsion in rat isolated intestinal membrane by the Ussing chamber method. Drug Metab. Pharmacokinet. 21 (2006) 45-53
11. Aten R.F., Kolodecik T.R., and Behrman H.R. Ovarian vitamin E accumulation: Evidence for a role of lipoproteins. Endocrinology 135 (1994) 533-539
12. Atkinson J. Chemical investigations of tocotrienols: Isotope substitution, fluorophores and a curious curve. In: Nesaretnam K. (Ed). "6th COSTAM/SFRR (ASEAN/Malaysia) International Workshop on Micronutrients, Oxidative Stress, and the Environment" (2005), Kuching, Malaysia 22 COSTAM
13. Azlina M.F., Nafeeza M.I., and Khalid B.A. A comparison between tocopherol and tocotrienol effects on gastric parameters in rats exposed to stress. Asia Pac. J. Clin. Nutr. 14 (2005) 358-365
14. Azzi A., and Stocker A. Vitamin E: Non-antioxidant roles. Prog. Lipid Res. 39 (2000) 231-255
15. Azzi A., Boscoboinik D., Marilley D., Ozer N.K., Stauble B., and Tasinato A. Vitamin E: A sensor and an information transducer of the cell oxidation state. Am. J. Clin. Nutr. 62 (1995) 1337S-1346S
16. Bains J.S., and Shaw C.A. Neurodegenerative disorders in humans: The role of glutathione in oxidative stress-mediated neuronal death. Brain Res. Brain Res. Rev. 25 (1997) 335-358
17. Baliarsingh S., Beg Z.H., and Ahmad J. The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia. Atherosclerosis 182 (2005) 367-374
18. Bazan Jr. N.G. Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim. Biophys. Acta 218 (1970) 1-10
19. Bazan Jr. N.G. Changes in free fatty acids of brain by drug-induced convulsions, electroshock and anaesthesia. J. Neurochem. 18 (1971) 1379-1385
20. Bazan Jr. N.G. Phospholipases A 1 and A 2 in brain subcellular fractions. Acta Physiol. Lat. Am. 21 (1971) 101-106
21. Bazan N.G. Free arachidonic acid and other lipids in the nervous system during early ischemia and after electroshock. Adv. Exp. Med. Biol. 72 (1976) 317-335
22. Bazan Jr. N.G., and Rakowski H. Increased levels of brain free fatty acids after electroconvulsive shock. Life Sci. 9 (1970) 501-507
23. Begum A.N., and Terao J. Protective effect of α-tocotrienol against free radical-induced impairment of erythrocyte deformability. Biosci. Biotechnol. Biochem. 66 (2002) 398-403
24. Bhat N.R., and Zhang P. Hydrogen peroxide activation of multiple mitogen-activated protein kinases in an oligodendrocyte cell line: Role of extracellular signal-regulated kinase in hydrogen peroxide-induced cell death. J. Neurochem. 72 (1999) 112-119
25. Birringer M., Pfluger P., Kluth D., Landes N., and Brigelius-Flohe R. Identities and differences in the metabolism of tocotrienols and tocopherols in HepG2 cells. J. Nutr. 132 (2002) 3113-3118
26. Birringer M., EyTina J.H., Salvatore B.A., and Neuzil J. Vitamin E analogues as inducers of apoptosis: Structure-function relation. Br. J. Cancer 88 (2003) 1948-1955
27. Black T.M., Wang P., Maeda N., and Coleman R.A. Palm tocotrienols protect ApoE+/- mice from diet-induced atheroma formation. J. Nutr. 130 (2000) 2420-2426
28. Blatt D.H., Leonard S.W., and Traber M.G. Vitamin E kinetics and the function of tocopherol regulatory proteins. Nutrition 17 (2001) 799-805
29. Borngraber S., Browner M., Gillmor S., Gerth C., Anton M., Fletterick R., and Kuhn H. Shape and specificity in mammalian 15-lipoxygenase active site. The functional interplay of sequence determinants for the reaction specificity. J. Biol. Chem. 274 (1999) 37345-37350
30. Boscoboinik D., Szewczyk A., Hensey C., and Azzi A. Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. J. Biol. Chem. 266 (1991) 6188-6194
31. Brugge J.S., Cotton P.C., Queral A.E., Barrett J.N., Nonner D., and Keane R.W. Neurones express high levels of a structurally modified, activated form of pp60c-src. Nature 316 (1985) 554-557
32. Bruno R.S., and Traber M.G. Vitamin E biokinetics, oxidative stress and cigarette smoking. Pathophysiology 13 (2006) 143-149
33. Bryngelsson S., Dimberg L.H., and Kamal-Eldin A. Effects of commercial processing on levels of antioxidants in oats (Avena sativa L.). J. Agric. Food Chem. 50 (2002) 1890-1896
34. Cahoon E.B., Hall S.E., Ripp K.G., Ganzke T.S., Hitz W.D., and Coughlan S.J. Metabolic redesign of vitamin E biosynthesis in plants for tocotrienol production and increased antioxidant content. Nat. Biotechnol. 21 (2003) 1082-1087
35. Carlen P.L., Gurevich N., Zhang L., Wu P.H., Reynaud D., and Pace-Asciak C.R. Formation and electrophysiological actions of the arachidonic acid metabolites, hepoxilins, at nanomolar concentrations in rat hippocampal slices. Neuroscience 58 (1994) 493-502
36. Chao J.T., Gapor A., and Theriault A. Inhibitory effect of δ-tocotrienol, a HMG CoA reductase inhibitor, on monocyte-endothelial cell adhesion. J. Nutr. Sci. Vitaminol. (Tokyo) 48 (2002) 332-337
37. Chen C.W., and Cheng H.H. A rice bran oil diet increases LDL-receptor and HMG-CoA reductase mRNA expressions and insulin sensitivity in rats with streptozotocin/nicotinamide-induced type 2 diabetes. J. Nutr. 136 (2006) 1472-1476
38. Chow C.K., and Draper H.H. Isolation of γ-tocotrienol dimers from Hevea latex. Biochemistry 9 (1970) 445-450
39. Collins J.J., Evason K., and Kornfeld K. Pharmacology of delayed aging and extended lifespan of Caenorhabditis elegans. Exp. Gerontol. 41 10 (2006) 1032-1039
40. Das S., Powell S.R., Wang P., Divald A., Nesaretnam K., Tosaki A., Cordis G.A., Maulik N., and Das D.K. Cardioprotection with palm tocotrienol: Antioxidant activity of tocotrienol is linked with its ability to stabilize proteasomes. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H361-H367
41. Dietrich M., Traber M.G., Jacques P.F., Cross C.E., Hu Y., and Block G. Does γ-tocopherol play a role in the primary prevention of heart disease and cancer? A review. J. Am. Coll. Nutr. 25 (2006) 292-299
42. Dringen R., Gutterer J.M., and Hirrlinger J. Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem. 267 (2000) 4912-4916
43. Eitsuka T., Nakagawa K., and Miyazawa T. Down-regulation of telomerase activity in DLD-1 human colorectal adenocarcinoma cells by tocotrienol. Biochem. Biophys. Res. Commun. 348 1 (2006) 170-175
44. Elson C.E. Tropical oils: Nutritional and scientific issues. Crit. Rev. Food Sci. Nutr. 31 (1992) 79-102
45. Elson C.E., and Qureshi A.A. Coupling the cholesterol- and tumor-suppressive actions of palm oil to the impact of its minor constituents on 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. Prostaglandins Leukot. Essent. Fatty Acids 52 (1995) 205-207
46. Evans H.M., and Bishop K.S. On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science 56 (1922) 650-651
47. Fairus S., Rosnah M.N., Cheng H.M., and Sundram K. Metabolic fate of palm tocotrienols in human postprandial plasma model. Asia Pac. J. Clin. Nutr. 13 (2004) S77
48. Friedrich M.J. To "E" or not to "E," vitamin E's role in health and disease is the question. JAMA 292 (2004) 671-673
49. Gao P., and Morozowich W. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin. Drug Deliv. 3 (2006) 97-110
50. Garry P.J., Hunt W.C., Bandrofchak J.L., VanderJagt D., and Goodwin J.S. Vitamin A intake and plasma retinol levels in healthy elderly men and women. Am. J. Clin. Nutr. 46 (1987) 989-994
51. Goh S.H., Hew N.F., Norhanom A.W., and Yadav M. Inhibition of tumour promotion by various palm-oil tocotrienols. Int. J. Cancer 57 (1994) 529-531
52. Gorman C. Vitamin E-gads. Time 165 (2005) 73
53. Gould M.N., Haag J.D., Kennan W.S., Tanner M.A., and Elson C.E. A comparison of tocopherol and tocotrienol for the chemoprevention of chemically induced rat mammary tumors. Am. J. Clin. Nutr. 53 (1991) 1068S-1070S
54. Greenberg E.R. Vitamin E supplements: Good in theory, but is the theory good?. Ann. Intern. Med. 142 (2005) 75-76
55. Grossman S., and Waksman E.G. New aspects of the inhibition of soybean lipoxygenase by α-tocopherol. Evidence for the existence of a specific complex. Int. J. Biochem. 16 (1984) 281-289
56. Gu J., Liu Y., Wen Y., Natarajan R., Lanting L., and Nadler J.L. Evidence that increased 12-lipoxygenase activity induces apoptosis in fibroblasts. J. Cell. Physiol. 186 (2001) 357-365
57. Gu J.Y., Wakizono Y., Sunada Y., Hung P., Nonaka M., Sugano M., and Yamada K. Dietary effect of tocopherols and tocotrienols on the immune function of spleen and mesenteric lymph node lymphocytes in Brown Norway rats. Biosci. Biotechnol. Biochem. 63 (1999) 1697-1702
58. Guthrie N., Gapor A., Chambers A.F., and Carroll K.K. Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination. J. Nutr. 127 (1997) 544S-548S
59. Hagmann W., Kagawa D., Renaud C., and Honn K.V. Activity and protein distribution of 12-lipoxygenase in HEL cells: Induction of membrane-association by phorbol ester TPA, modulation of activity by glutathione and 13-HPODE, and Ca(2+)-dependent translocation to membranes. Prostaglandins 46 (1993) 471-477
60. Hall T.J., Schaeublin M., and Missbach M. Evidence that c-src is involved in the process of osteoclastic bone resorption. Biochem. Biophys. Res. Commun. 199 (1994) 1237-1244
61. Han D., Sen C.K., Roy S., Kobayashi M.S., Tritschler H.J., and Packer L. Protection against glutamate-induced cytotoxicity in C6 glial cells by thiol antioxidants. Am. J. Physiol. 273 (1997) R1771-R1778
62. Har C.H., and Keong C.K. Effects of tocotrienols on cell viability and apoptosis in normal murine liver cells (BNL CL.2) and liver cancer cells (BNL 1ME A.7R.1), in vitro. Asia Pac. J. Clin. Nutr. 14 (2005) 374-380
63. Hathcock J.N., Azzi A., Blumberg J., Bray T., Dickinson A., Frei B., Jialal I., Johnston C.S., Kelly F.J., Kraemer K., Packer L., Parthasarathy S., et al. Vitamins E and C are safe across a broad range of intakes. Am. J. Clin. Nutr. 81 (2005) 736-745
64. Hattori A., Fukushima T., Yoshimura H., Abe K., and Imai K. Production of LLU-α following an oral administration of γ-tocotrienol or γ-tocopherol to rats. Biol. Pharm. Bull. 23 (2000) 1395-1397
65. Hayes K.C., Pronczuk A., and Liang J.S. Differences in the plasma transport and tissue concentrations of tocopherols and tocotrienols: Observations in humans and hamsters. Proc. Soc. Exp. Biol. Med. 202 (1993) 353-359
66. He L., Mo H., Hadisusilo S., Qureshi A.A., and Elson C.E. Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J. Nutr. 127 (1997) 668-674
67. Hensley K., Benaksas E.J., Bolli R., Comp P., Grammas P., Hamdheydari L., Mou S., Pye Q.N., Stoddard M.F., Wallis G., Williamson K.S., West M., et al. New perspectives on vitamin E: γ-Tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine. Free Radic. Biol. Med. 36 (2004) 1-15
68. Ho D., Yuen K.H., and Yap S.P. Drug delivery system: Formulation for fat-soluble drugs. US patent 6 (2003) 596 306
69. Hong J.Y., Kim J.K., Song Y.K., Park J.S., and Kim C.K. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. J. Control. Release 110 (2006) 332-338
70. Horvath G., Wessjohann L., Bigirimana J., Jansen M., Guisez Y., Caubergs R., and Horemans N. Differential distribution of tocopherols and tocotrienols in photosynthetic and non-photosynthetic tissues. Phytochemistry 67 (2006) 1185-1195
71. Hosomi A., Arita M., Sato Y., Kiyose C., Ueda T., Igarashi O., Arai H., and Inoue K. Affinity for α-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett. 409 (1997) 105-108
72. Hsu C.Y., Persons P.E., Spada A.P., Bednar R.A., Levitzki A., and Zilberstein A. Kinetic analysis of the inhibition of the epidermal growth factor receptor tyrosine kinase by Lavendustin-A and its analogue. J. Biol. Chem. 266 (1991) 21105-21112
73. Ikeda I., Imasato Y., Sasaki E., and Sugano M. Lymphatic transport of α-, γ- and δ-tocotrienols and α-tocopherol in rats. Int. J. Vitam. Nutr. Res. 66 (1996) 217-221
74. Ikeda S., Niwa T., and Yamashita K. Selective uptake of dietary tocotrienols into rat skin. J. Nutr. Sci. Vitaminol. (Tokyo) 46 (2000) 141-143
75. Ikeda S., Toyoshima K., and Yamashita K. Dietary sesame seeds elevate α- and γ-tocotrienol concentrations in skin and adipose tissue of rats fed the tocotrienol-rich fraction extracted from palm oil. J. Nutr. 131 (2001) 2892-2897
76. Ikeda S., Tohyama T., Yoshimura H., Hamamura K., Abe K., and Yamashita K. Dietary α-tocopherol decreases α-tocotrienol but not γ-tocotrienol concentration in rats. J. Nutr. 133 (2003) 428-434
77. Ima-Nirwana S., and Suhaniza S. Effects of tocopherols and tocotrienols on body composition and bone calcium content in adrenalectomized rats replaced with dexamethasone. J. Med. Food 7 (2004) 45-51
78. Ingraham C.A., Cox M.E., Ward D.C., Fults D.W., and Maness P.F. c-src and other proto-oncogenes implicated in neuronal differentiation. Mol. Chem. Neuropathol. 10 (1989) 1-14
79. Inokuchi H., Hirokane H., Tsuzuki T., Nakagawa K., Igarashi M., and Miyazawa T. Anti-angiogenic activity of tocotrienol. Biosci. Biotechnol. Biochem. 67 (2003) 1623-1627
80. Iqbal J., Minhajuddin M., and Beg Z.H. Suppression of 7,12-dimethylbenz[α]anthracene-induced carcinogenesis and hypercholesterolaemia in rats by tocotrienol-rich fraction isolated from rice bran oil. Eur. J. Cancer Prev. 12 (2003) 447-453
81. Iqbal J., Minhajuddin M., and Beg Z.H. Suppression of diethylnitrosamine and 2-acetylaminofluorene-induced hepatocarcinogenesis in rats by tocotrienol-rich fraction isolated from rice bran oil. Eur. J. Cancer Prev. 13 (2004) 515-520
82. Ishizaki Y., and Murota S. Arachidonic acid metabolism in cultured astrocytes: Presence of 12-lipoxygenase activity in the intact cells. Neurosci. Lett. 131 (1991) 149-152
83. Ishizawar R., and Parsons S.J. c-Src and cooperating partners in human cancer. Cancer Cell 6 (2004) 209-214
84. Jishage K., Arita M., Igarashi K., Iwata T., Watanabe M., Ogawa M., Ueda O., Kamada N., Inoue K., Arai H., and Suzuki H. Alpha-tocopherol transfer protein is important for the normal development of placental labyrinthine trophoblasts in mice. J. Biol. Chem. 276 (2001) 1669-1672
85. Johnson N.L., Gardner A.M., Diener K.M., Lange-Carter C.A., Gleavy J., Jarpe M.B., Minden A., Karin M., Zon L.I., and Johnson G.L. Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death. J. Biol. Chem. 271 (1996) 3229-3237
86. Kaempf-Rotzoll D.E., Traber M.G., and Arai H. Vitamin E and transfer proteins. Curr. Opin. Lipidol. 14 (2003) 249-254
87. Kagan V.E., Serbinova E.A., Forte T., Scita G., and Packer L. Recycling of vitamin E in human low density lipoproteins. J. Lipid Res. 33 (1992) 385-397
88. Kaku S., Yunoki S., Mori M., Ohkura K., Nonaka M., Sugano M., and Yamada K. Effect of dietary antioxidants on serum lipid contents and immunoglobulin productivity of lymphocytes in Sprague-Dawley rats. Biosci. Biotechnol. Biochem. 63 (1999) 575-576
89. Kamat J.P., and Devasagayam T.P. Tocotrienols from palm oil as potent inhibitors of lipid peroxidation and protein oxidation in rat brain mitochondria. Neurosci. Lett. 195 (1995) 179-182
90. Kanaya Y., Doi T., Sasaki H., Fujita A., Matsuno S., Okamoto K., Nakano Y., Tsujiwaki S., Furuta H., Nishi M., Tsuno T., Taniguchi H., et al. Rice bran extract prevents the elevation of plasma peroxylipid in KKAy diabetic mice. Diabetes Res. Clin. Pract. 66 Suppl. 1 (2004) S157-S160
91. Khanna S., Venojarvi M., Roy S., and Sen C.K. Glutamate-induced c-Src activation in neuronal cells. Methods Enzymol. 352 (2002) 191-198
92. Khanna S., Roy S., Ryu H., Bahadduri P., Swaan P.W., Ratan R.R., and Sen C.K. Molecular basis of vitamin E action: Tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. J. Biol. Chem. 278 (2003) 43508-43515
93. Khanna S., Patel V., Rink C., Roy S., and Sen C.K. Delivery of orally supplemented α-tocotrienol to vital organs of rats and tocopherol-transport protein deficient mice. Free Radic. Biol. Med. 39 (2005) 1310-1319
94. Khanna S., Roy S., Slivka A., Craft T.K., Chaki S., Rink C., Notestine M.A., DeVries A.C., Parinandi N.L., and Sen C.K. Neuroprotective properties of the natural vitamin E α-tocotrienol. Stroke 36 (2005) 2258-2264
95. Khanna S., Roy S., Parinandi N.L., Maurer M., and Sen C.K. Characterization of the potent neuroprotective properties of the natural vitamin E α-tocotrienol. J. Neurochem. 98 5 (2006) 1474-1486
96. Khosla P., Patel V., Whinter J.M., Khanna S., Rakhkovskaya M., Roy S., and Sen C.K. Postprandial levels of the natural vitamin E tocotrienol in human circulation. Antioxid. Redox Signal. 8 (2006) 1059-1068
97. Kitagawa K., Matsumoto M., and Hori M. Cerebral ischemia in 5-lipoxygenase knockout mice. Brain Res. 1004 (2004) 198-202
98. Kluth D., Landes N., Pfluger P., Muller-Schmehl K., Weiss K., Bumke-Vogt C., Ristow M., and Brigelius-Flohe R. Modulation of Cyp3a11 mRNA expression by α-tocopherol but not γ-tocotrienol in mice. Free Radic. Biol. Med. 38 (2005) 507-514
99. Koba K., Abe K., Ikeda I., and Sugano M. Effects of α-tocopherol and tocotrienols on blood pressure and linoleic acid metabolism in the spontaneously hypertensive rat (SHR). Biosci. Biotechnol. Biochem. 56 (1992) 1420-1423
100. Komiyama K., Iizuka K., Yamaoka M., Watanabe H., Tsuchiya N., and Umezawa I. Studies on the biological activity of tocotrienols. Chem. Pharm. Bull. 37 (1989) 1369-1371
101. Kumar K.S., Raghavan M., Hieber K., Ege C., Mog S., Parra N., Hildabrand A., Singh V., Srinivasan V., Toles R., Karikari P., Petrovics G., et al. Preferential radiation sensitization of prostate cancer in nude mice by nutraceutical antioxidant γ-tocotrienol. Life Sci. 78 (2006) 2099-2104
102. Kwon K.J., Jung Y.S., Lee S.H., Moon C.H., and Baik E.J. Arachidonic acid induces neuronal death through lipoxygenase and cytochrome P450 rather than cyclooxygenase. J. Neurosci. Res. 81 (2005) 73-84
103. Landes N., Pfluger P., Kluth D., Birringer M., Ruhl R., Bol G.F., Glatt H., and Brigelius-Flohe R. Vitamin E activates gene expression via the pregnane X receptor. Biochem. Pharmacol. 65 (2003) 269-273
104. Lau A.F. c-Src: Bridging the gap between phosphorylation- and acidification-induced gap junction channel closure. Sci. STKE 2005 (2005) pe33
105. Lebeau A., Esclaire F., Rostene W., and Pelaprat D. Baicalein protects cortical neurons from β-amyloid (25-35) induced toxicity. Neuroreport 12 (2001) 2199-2202
106. Lee J.R., and Koretzky G.A. Extracellular signal-regulated kinase-2, but not c-Jun NH2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line. J. Immunol. 161 (1998) 1637-1644
107. Lennmyr F., Ericsson A., Gerwins P., Akterin S., Ahlstrom H., and Terent A. Src family kinase-inhibitor PP2 reduces focal ischemic brain injury. Acta Neurol. Scand. 110 (2004) 175-179
108. Leonard S.W., Paterson E., Atkinson J.K., Ramakrishnan R., Cross C.E., and Traber M.G. Studies in humans using deuterium-labeled α- and γ-tocopherols demonstrate faster plasma γ-tocopherol disappearance and greater γ-metabolite production. Free Radic. Biol. Med. 38 (2005) 857-866
109. Lepley R.A., Muskardin D.T., and Fitzpatrick F.A. Tyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase. J. Biol. Chem. 271 (1996) 6179-6184
110. Li Y., Maher P., and Schubert D. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19 (1997) 453-463
111. Lodge J.K., Ridlington J., Leonard S., Vaule H., and Traber M.G. Alpha- and γ-tocotrienols are metabolized to carboxyethyl-hydroxychroman derivatives and excreted in human urine. Lipids 36 (2001) 43-48
112. Lodge J.K., Hall W.L., Jeanes Y.M., and Proteggente A.R. Physiological factors influencing vitamin e biokinetics. Ann. NY Acad. Sci. 1031 (2004) 60-73
113. Maness P.F., Aubry M., Shores C.G., Frame L., and Pfenninger K.H. c-src gene product in developing rat brain is enriched in nerve growth cone membranes. Proc. Natl. Acad. Sci. USA 85 (1988) 5001-5005
114. Mazlan M., Sue Mian T., Mat Top G., and Zurinah Wan Ngah W. Comparative effects of α-tocopherol and γ-tocotrienol against hydrogen peroxide induced apoptosis on primary-cultured astrocytes. J. Neurol. Sci. 243 (2006) 5-12
115. McIntyre B.S., Briski K.P., Gapor A., and Sylvester P.W. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc. Soc. Exp. Biol. Med. 224 (2000) 292-301
116. McIntyre B.S., Briski K.P., Tirmenstein M.A., Fariss M.W., Gapor A., and Sylvester P.W. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells. Lipids 35 (2000) 171-180
117. Mensink R.P., van Houwelingen A.C., Kromhout D., and Hornstra G. A vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations. Am. J. Clin. Nutr. 69 (1999) 213-219
118. Meyenberg A., Goldblum D., Zingg J.M., Azzi A., Nesaretnam K., Kilchenmann M., and Frueh B.E. Tocotrienol inhibits proliferation of human Tenon's fibroblasts in vitro: A comparative study with vitamin E forms and mitomycin C. Graefes Arch. Clin. Exp. Ophthalmol. 243 (2005) 1263-1271
119. Miller III E.R., Pastor-Barriuso R., Dalal D., Riemersma R.A., Appel L.J., and Guallar E. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 142 (2005) 37-46
120. Minhajuddin M., Beg Z.H., and Iqbal J. Hypolipidemic and antioxidant properties of tocotrienol rich fraction isolated from rice bran oil in experimentally induced hyperlipidemic rats. Food Chem. Toxicol. 43 (2005) 747-753
121. Mishima K., Tanaka T., Pu F., Egashira N., Iwasaki K., Hidaka R., Matsunaga K., Takata J., Karube Y., and Fujiwara M. Vitamin E isoforms α-tocotrienol and γ-tocopherol prevent cerebral infarction in mice. Neurosci. Lett. 337 (2003) 56-60
122. Miyamoto T., Lindgren J.A., Hokfelt T., and Samuelsson B. Formation of lipoxygenase products in the rat brain. Adv. Prostaglandin Thromboxane Leukot. Res. 17B (1987) 929-933
123. Miyamoto T., Lindgren J.A., Hokfelt T., and Samuelsson B. Regional distribution of leukotriene and mono-hydroxyeicosatetraenoic acid production in the rat brain. Highest leukotriene C4 formation in the hypothalamus. FEBS Lett. 216 (1987) 123-127
124. Miyazawa T., Inokuchi H., Hirokane H., Tsuzuki T., Nakagawa K., and Igarashi M. Anti-angiogenic potential of tocotrienol in vitro. Biochemistry (Mosc.) 69 (2004) 67-69
125. Mizushina Y., Nakagawa K., Shibata A., Awata Y., Kuriyama I., Shimazaki N., Koiwai O., Uchiyama Y., Sakaguchi K., Miyazawa T., and Yoshida H. Inhibitory effect of tocotrienol on eukaryotic DNA polymerase lambda and angiogenesis. Biochem. Biophys. Res. Commun. 339 (2006) 949-955
126. Mo H., and Elson C.E. Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids. J. Nutr. 129 (1999) 804-813
127. Musiek E.S., Breeding R.S., Milne G.L., Zanoni G., Morrow J.D., and McLaughlin B. Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration. J. Neurochem. 97 (2006) 1301-1313
128. Nafeeza M.I., and Kang T.T. Synergistic effects of tocopherol, tocotrienol, and ubiquinone in indomethacin-induced experimental gastric lesions. Int. J. Vitam. Nutr. Res. 75 (2005) 149-155
129. Nafeeza M.I., Fauzee A.M., Kamsiah J., and Gapor M.T. Comparative effects of a tocotrienol-rich fraction and tocopherol in aspirin-induced gastric lesions in rats. Asia Pac. J. Clin. Nutr. 11 (2002) 309-313
130. Naguib Y., Hari S.P., Passwater Jr. R., and Huang D. Antioxidant activities of natural vitamin E formulations. J. Nutr. Sci. Vitaminol. (Tokyo) 49 (2003) 217-220
131. Naito Y., Shimozawa M., Kuroda M., Nakabe N., Manabe H., Katada K., Kokura S., Ichikawa H., Yoshida N., Noguchi N., and Yoshikawa T. Tocotrienols reduce 25-hydroxycholesterol-induced monocyte-endothelial cell interaction by inhibiting the surface expression of adhesion molecules. Atherosclerosis 180 (2005) 19-25
132. Nakagawa K., Eitsuka T., Inokuchi H., and Miyazawa T. DNA chip analysis of comprehensive food function: Inhibition of angiogenesis and telomerase activity with unsaturated vitamin E, tocotrienol. Biofactors 21 (2004) 5-10
133. Nesaretnam K., Guthrie N., Chambers A.F., and Carroll K.K. Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids 30 (1995) 1139-1143
134. Nesaretnam K., Stephen R., Dils R., and Darbre P. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 33 (1998) 461-469
135. Nesaretnam K., Dorasamy S., and Darbre P.D. Tocotrienols inhibit growth of ZR-75-1 breast cancer cells. Int. J. Food Sci. Nutr. 51 Suppl. (2000) S95-S103
136. Nesaretnam K., Ambra R., Selvaduray K.R., Radhakrishnan A., Reimann K., Razak G., and Virgili F. Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice. Lipids 39 (2004) 459-467
137. Newaz M.A., and Nawal N.N. Effect of γ-tocotrienol on blood pressure, lipid peroxidation and total antioxidant status in spontaneously hypertensive rats (SHR). Clin. Exp. Hypertens. (New York) 21 (1999) 1297-1313
138. Newaz M.A., Yousefipour Z., Nawal N., and Adeeb N. Nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats: Antioxidant protection by γ-tocotrienol. J. Physiol. Pharmacol. 54 (2003) 319-327
139. Ngah W.Z., Jarien Z., San M.M., Marzuki A., Top G.M., Shamaan N.A., and Kadir K.A. Effect of tocotrienols on hepatocarcinogenesis induced by 2-acetylaminofluorene in rats. Am. J. Clin. Nutr. 53 (1991) 1076S-1081S
140. Nishiyama M., Okamoto H., Watanabe T., Hori T., Hada T., Ueda N., Yamamoto S., Tsukamoto H., Watanabe K., and Kirino T. Localization of arachidonate 12-lipoxygenase in canine brain tissues. J. Neurochem. 58 (1992) 1395-1400
141. Nishiyama M., Watanabe T., Ueda N., Tsukamoto H., and Watanabe K. Arachidonate 12-lipoxygenase is localized in neurons, glial cells, and endothelial cells of the canine brain. J. Histochem. Cytochem. 41 (1993) 111-117
142. Noguchi N., Hanyu R., Nonaka A., Okimoto Y., and Kodama T. Inhibition of THP-1 cell adhesion to endothelial cells by α-tocopherol and α-tocotrienol is dependent on intracellular concentration of the antioxidants. Free Radic. Biol. Med. 34 (2003) 1614-1620
143. Norazlina M., Ima-Nirwana S., Abul Gapor M.T., and Abdul Kadir Khalid B. Tocotrienols are needed for normal bone calcification in growing female rats. Asia Pac. J. Clin. Nutr. 11 (2002) 194-199
144. Numakawa Y., Numakawa T., Matsumoto T., Yagasaki Y., Kumamaru E., Kunugi H., Taguchi T., and Niki E. Vitamin E protected cultured cortical neurons from oxidative stress-induced cell death through the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. J. Neurochem. 97 (2006) 1191-1202
145. O'Byrne D., Grundy S., Packer L., Devaraj S., Baldenius K., Hoppe P.P., Kraemer K., Jialal I., and Traber M.G. Studies of LDL oxidation following α-, γ-, or δ-tocotrienyl acetate supplementation of hypercholesterolemic humans. Free Radic. Biol. Med. 29 (2000) 834-845
146. Okabe M., Oji M., Ikeda I., Tachibana H., and Yamada K. Tocotrienol levels in various tissues of Sprague-Dawley rats after intragastric administration of tocotrienols. Biosci. Biotechnol. Biochem. 66 (2002) 1768-1771
147. Osakada F., Hashino A., Kume T., Katsuki H., Kaneko S., and Akaike A. α-Tocotrienol provides the most potent neuroprotection among vitamin E analogs on cultured striatal neurons. Neuropharmacology 47 (2004) 904-915
148. Palozza P., Verdecchia S., Avanzi L., Vertuani S., Serini S., Iannone A., and Manfredini S. Comparative antioxidant activity of tocotrienols and the novel chromanyl-polyisoprenyl molecule FeAox-6 in isolated membranes and intact cells. Mol. Cell. Biochem. 287 (2006) 21-32
149. Panfili G., Fratianni A., and Irano M. Normal phase high-performance liquid chromatography method for the determination of tocopherols and tocotrienols in cereals. J. Agric. Food Chem. 51 (2003) 3940-3944
150. Parker R.A., Pearce B.C., Clark R.W., Gordon D.A., and Wright J.J. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Biol. Chem. 268 (1993) 11230-11238
151. Paul R., Zhang Z.G., Eliceiri B.P., Jiang Q., Boccia A.D., Zhang R.L., Chopp M., and Cheresh D.A. Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat. Med. 7 (2001) 222-227
152. Pearce B.C., Parker R.A., Deason M.E., Qureshi A.A., and Wright J.J. Hypocholesterolemic activity of synthetic and natural tocotrienols. J. Med. Chem. 35 (1992) 3595-3606
153. Pearce B.C., Parker R.A., Deason M.E., Dischino D.D., Gillespie E., Qureshi A.A., Volk K., and Wright J.J. Inhibitors of cholesterol biosynthesis. 2. Hypocholesterolemic and antioxidant activities of benzopyran and tetrahydronaphthalene analogues of the tocotrienols. J. Med. Chem. 37 (1994) 526-541
154. Podda M., Weber C., Traber M.G., and Packer L. Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols, and ubiquinones. J. Lipid Res. 37 (1996) 893-901
155. Porfirova S., Bergmuller E., Tropf S., Lemke R., and Dormann P. Isolation of an Arabidopsis mutant lacking vitamin E and identification of a cyclase essential for all tocopherol biosynthesis. Proc. Natl. Acad. Sci. USA 99 (2002) 12495-12500
156. Pyper J.M., and Bolen J.B. Neuron-specific splicing of C-SRC RNA in human brain. J. Neurosci. Res. 24 (1989) 89-96
157. Qureshi A.A., and Peterson D.M. The combined effects of novel tocotrienols and lovastatin on lipid metabolism in chickens. Atherosclerosis 156 (2001) 39-47
158. Qureshi A.A., Burger W.C., Peterson D.M., and Elson C.E. The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J. Biol. Chem. 261 (1986) 10544-10550
159. Qureshi A.A., Qureshi N., Hasler-Rapacz J.O., Weber F.E., Chaudhary V., Crenshaw T.D., Gapor A., Ong A.S., Chong Y.H., and Peterson D. Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias. Am. J. Clin. Nutr. 53 (1991) 1042S-1046S
160. Qureshi A.A., Qureshi N., Wright J.J., Shen Z., Kramer G., Gapor A., Chong Y.H., DeWitt G., Ong A., and Peterson D.M. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). Am. J. Clin. Nutr. 53 (1991) 1021S-1026S
161. Qureshi A.A., Bradlow B.A., Brace L., Manganello J., Peterson D.M., Pearce B.C., Wright J.J., Gapor A., and Elson C.E. Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids 30 (1995) 1171-1177
162. Qureshi A.A., Mo H., Packer L., and Peterson D.M. Isolation and identification of novel tocotrienols from rice bran with hypocholesterolemic, antioxidant, and antitumor properties. J. Agric. Food Chem. 48 (2000) 3130-3140
163. Qureshi A.A., Peterson D.M., Hasler-Rapacz J.O., and Rapacz J. Novel tocotrienols of rice bran suppress cholesterogenesis in hereditary hypercholesterolemic swine. J. Nutr. 131 (2001) 223-230
164. Qureshi A.A., Salser W.A., Parmar R., and Emeson E.E. Novel tocotrienols of rice bran inhibit atherosclerotic lesions in C57BL/6 ApoE-deficient mice. J. Nutr. 131 (2001) 2606-2618
165. Qureshi A.A., Sami S.A., Salser W.A., and Khan F.A. Synergistic effect of tocotrienol-rich fraction (TRF(25)) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans. J. Nutr. Biochem. 12 (2001) 318-329
166. Qureshi A.A., Sami S.A., Salser W.A., and Khan F.A. Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans. Atherosclerosis 161 (2002) 199-207
167. Raederstorff D., Elste V., Aebischer C., and Weber P. Effect of either γ-tocotrienol or a tocotrienol mixture on the plasma lipid profile in hamsters. Ann. Nutr. Metab. 46 (2002) 17-23
168. Rahmat A., Ngah W.Z., Shamaan N.A., Gapor A., and Abdul Kadir K. Long-term administration of tocotrienols and tumor-marker enzyme activities during hepatocarcinogenesis in rats. Nutrition 9 (1993) 229-232
169. Reddanna P., Rao M.K., and Reddy C.C. Inhibition of 5-lipoxygenase by vitamin E. FEBS Lett. 193 (1985) 39-43
170. Rippert P., Scimemi C., Dubald M., and Matringe M. Engineering plant shikimate pathway for production of tocotrienol and improving herbicide resistance. Plant Physiol. 134 (2004) 92-100
171. Roy S., Lado B.H., Khanna S., and Sen C.K. Vitamin E sensitive genes in the developing rat fetal brain: A high-density oligonucleotide microarray analysis. FEBS Lett. 530 (2002) 17-23
172. Saito H., Kiyose C., Yoshimura H., Ueda T., Kondo K., and Igarashi O. γ-Tocotrienol, a vitamin E homolog, is a natriuretic hormone precursor. J. Lipid Res. 44 (2003) 1530-1535
173. Sakai M., Okabe M., Yamasaki M., Tachibana H., and Yamada K. Induction of apoptosis by tocotrienol in rat hepatoma dRLh-84 cells. Anticancer Res. 24 (2004) 1683-1688
174. Sakai M., Okabe M., Tachibana H., and Yamada K. Apoptosis induction by gamma-tocotrienol in human hepatoma Hep3B cells. J. Nutr. Biochem. 17 10 (2005) 672-676
175. Schroeder M.T., Becker E.M., and Skibsted L.H. Molecular mechanism of antioxidant synergism of tocotrienols and carotenoids in palm oil. J. Agric. Food Chem. 54 (2006) 3445-3453
176. Schubert D., and Piasecki D. Oxidative glutamate toxicity can be a component of the excitotoxicity cascade. J. Neurosci. 21 (2001) 7455-7462
177. Schulz J.B., Lindenau J., Seyfried J., and Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem. 267 (2000) 4904-4911
178. Schwarz K. Role of vitamin E, selenium, and related factors in experimental nutritional liver disease. Fed. Proc. 24 (1965) 58-67
179. Schwedhelm E., Maas R., Troost R., and Boger R.H. Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress. Clin. Pharmacokinet. 42 (2003) 437-459
180. Sen C.K., Khanna S., Roy S., and Packer L. Molecular basis of vitamin E action. Tocotrienol potently inhibits glutamate-induced pp60(c-Src) kinase activation and death of HT4 neuronal cells. J. Biol. Chem. 275 (2000) 13049-13055
181. Sen C.K., Khanna S., and Roy S. Tocotrienol: The natural vitamin E to defend the nervous system?. Ann. NY Acad. Sci. 1031 (2004) 127-142
182. Sen C.K., Khanna S., and Roy S. Tocotrienols: Vitamin E beyond tocopherols. Life Sci. 78 (2006) 2088-2098
183. Serbinova E.A., and Packer L. Antioxidant properties of α-tocopherol and α-tocotrienol. Methods Enzymol. 234 (1994) 354-366
184. Serbinova E., Kagan V., Han D., and Packer L. Free radical recycling and intramembrane mobility in the antioxidant properties of α-tocopherol and α-tocotrienol. Free Radic. Biol. Med. 10 (1991) 263-275
185. Sever N., Song B.L., Yabe D., Goldstein J.L., Brown M.S., and DeBose-Boyd R.A. Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol. J. Biol. Chem. 278 (2003) 52479-52490
186. Shah S., and Sylvester P.W. Tocotrienol-induced caspase-8 activation is unrelated to death receptor apoptotic signaling in neoplastic mammary epithelial cells. Exp. Biol. Med. (Maywood) 229 (2004) 745-755
187. Shah S.J., and Sylvester P.W. Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity. Exp. Biol. Med. (Maywood) 230 (2005) 235-241
188. Shah S.J., and Sylvester P.W. Tocotrienol-induced cytotoxicity is unrelated to mitochondrial stress apoptotic signaling in neoplastic mammary epithelial cells. Biochem. Cell Biol. 83 (2005) 86-95
189. Shah S., Gapor A., and Sylvester P.W. Role of caspase-8 activation in mediating vitamin E-induced apoptosis in murine mammary cancer cells. Nutr. Cancer 45 (2003) 236-246
190. Shay J.W., and Wright W.E. Telomerase therapeutics for cancer: Challenges and new directions. Nat. Rev. Drug Discov. 5 (2006) 577-584
191. Shohami E., Glantz L., Nates J., and Feuerstein G. The mixed lipoxygenase/cyclooxygenase inhibitor SK&F 105809 reduces cerebral edema after closed head injury in rat. J. Basic. Clin. Physiol. Pharmacol. 3 (1992) 99-107
192. Shun M.C., Yu W., Gapor A., Parsons R., Atkinson J., Sanders B.G., and Kline K. Pro-apoptotic mechanisms of action of a novel vitamin E analog (α-TEA) and a naturally occurring form of vitamin E (δ-tocotrienol) in MDA-MB-435 human breast cancer cells. Nutr. Cancer 48 (2004) 95-105
193. Shupnik M.A. Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: Implications for cell proliferation. Oncogene 23 (2004) 7979-7989
194. Soelaiman I.N., Ahmad N.S., and Khalid B.A. Palm oil tocotrienol mixture is better than α-tocopherol acetate in protecting bones against free-radical induced elevation of bone-resorbing cytokines. Asia Pac. J. Clin. Nutr. 13 (2004) S111
195. Solomons N.W., and Orozco M. Alleviation of vitamin A deficiency with palm fruit and its products. Asia Pac. J. Clin. Nutr. 12 (2003) 373-384
196. Song B.L., and Debose-Boyd R.A. Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase stimulated by δ- and γ-tocotrienols. J. Biol. Chem. 281 (2006) 25054-25061
197. Sonnen A.F., Bakirci H., Netscher T., and Nau W.M. Effect of temperature, cholesterol content, and antioxidant structure on the mobility of vitamin E constituents in biomembrane models studied by laterally diffusion-controlled fluorescence quenching. J. Am. Chem. Soc. 127 (2005) 15575-15584
198. Soriano P., Montgomery C., Geske R., and Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64 (1991) 693-702
199. Srivastava J.K., and Gupta S. Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells. Biochem. Biophys. Res. Commun. 346 (2006) 447-453
200. Steiner M. Vitamin E: More than an antioxidant. Clin. Cardiol. 16 (1993) I16-I18
201. Suarna C., Hood R.L., Dean R.T., and Stocker R. Comparative antioxidant activity of tocotrienols and other natural lipid-soluble antioxidants in a homogeneous system, and in rat and human lipoproteins. Biochim. Biophys. Acta 1166 (1993) 163-170
202. Sugano M., Koba K., and Tsuji E. Health benefits of rice bran oil. Anticancer Res. 19 (1999) 3651-3657
203. Sun X., Shih A.Y., Johannssen H.C., Erb H., Li P., and Murphy T.H. Two-photon imaging of glutathione levels in intact brain indicates enhanced redox buffering in developing neurons and cells at the cerebrospinal fluid and blood-brain interface. J. Biol. Chem. 281 (2006) 17420-17431
204. Sundram K., Khor H.T., Ong A.S., and Pathmanathan R. Effect of dietary palm oils on mammary carcinogenesis in female rats induced by 7,12-dimethylbenz(a)anthracene. Cancer Res. 49 (1989) 1447-1451
205. Sundram K., Sambanthamurthi R., and Tan Y.A. Palm fruit chemistry and nutrition. Asia Pac. J. Clin. Nutr. 12 (2003) 355-362
206. Suzuki Y.J., Tsuchiya M., Wassall S.R., Choo Y.M., Govil G., Kagan V.E., and Packer L. Structural and dynamic membrane properties of α-tocopherol and α-tocotrienol: Implication to the molecular mechanism of their antioxidant potency. Biochemistry 32 (1993) 10692-10699
207. Sylvester P.W., and Shah S. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Asia Pac. J. Clin. Nutr. 14 (2005) 366-373
208. Sylvester P.W., and Shah S.J. Mechanisms mediating the antiproliferative and apoptotic effects of vitamin E in mammary cancer cells. Front Biosci. 10 (2005) 699-709
209. Sylvester P.W., McIntyre B.S., Gapor A., and Briski K.P. Vitamin E inhibition of normal mammary epithelial cell growth is associated with a reduction in protein kinase C(α) activation. Cell Prolif. 34 (2001) 347-357
210. Sylvester P.W., Nachnani A., Shah S., and Briski K.P. Role of GTP-binding proteins in reversing the antiproliferative effects of tocotrienols in preneoplastic mammary epithelial cells. Asia Pac. J. Clin. Nutr. 11 Suppl. 7 (2002) S452-S459
211. Sylvester P.W., Shah S.J., and Samant G.V. Intracellular signaling mechanisms mediating the antiproliferative and apoptotic effects of γ-tocotrienol in neoplastic mammary epithelial cells. J. Plant Physiol. 162 (2005) 803-810
212. Takahashi K., and Loo G. Disruption of mitochondria during tocotrienol-induced apoptosis in MDA-MB-231 human breast cancer cells. Biochem. Pharmacol. 67 (2004) 315-324
213. Tan D.T., Khor H.T., Low W.H., Ali A., and Gapor A. Effect of a palm-oil-vitamin E concentrate on the serum and lipoprotein lipids in humans. Am. J. Clin. Nutr. 53 (1991) 1027S-1030S
214. Tan S., Schubert D., and Maher P. Oxytosis: A novel form of programmed cell death. Curr. Top. Med. Chem. 1 (2001) 497-506
215. Tanito M., Itoh N., Yoshida Y., Hayakawa M., Ohira A., and Niki E. Distribution of tocopherols and tocotrienols to rat ocular tissues after topical ophthalmic administration. Lipids 39 (2004) 469-474
216. Tarrago-Trani M.T., Phillips K.M., Lemar L.E., and Holden J.M. New and existing oils and fats used in products with reduced trans-fatty acid content. J. Am. Diet. Assoc. 106 (2006) 867-880
217. Terasawa Y., Ladha Z., Leonard S.W., Morrow J.D., Newland D., Sanan D., Packer L., Traber M.G., and Farese Jr. R.V. Increased atherosclerosis in hyperlipidemic mice deficient in α-tocopherol transfer protein and vitamin E. Proc. Natl. Acad. Sci. USA 97 (2000) 13830-13834
218. Theriault A., Wang Q., Gapor A., and Adeli K. Effects of γ-tocotrienol on ApoB synthesis, degradation, and secretion in HepG2 cells. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 704-712
219. Theriault A., Chao J.T., and Gapor A. Tocotrienol is the most effective vitamin E for reducing endothelial expression of adhesion molecules and adhesion to monocytes. Atherosclerosis 160 (2002) 21-30
220. Thomas S.M., and Brugge J.S. Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 13 (1997) 513-609
221. Tiahou G., Maire B., Dupuy A., Delage M., Vernet M.H., Mathieu-Daude J.C., Michel F., Sess E.D., and Cristol J.P. Lack of oxidative stress in a selenium deficient area in Ivory Coast Potential nutritional antioxidant role of crude palm oil. Eur. J. Nutr. 43 (2004) 367-374
222. Tomeo A.C., Geller M., Watkins T.R., Gapor A., and Bierenbaum M.L. Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis. Lipids 30 (1995) 1179-1183
223. Traber M.G., and Arai H. Molecular mechanisms of vitamin E transport. Annu. Rev. Nutr. 19 (1999) 343-355
224. Traber M.G., Burton G.W., and Hamilton R.L. Vitamin E trafficking. Ann. NY Acad. Sci. 1031 (2004) 1-12
225. van der Worp H.B., Bar P.R., Kappelle L.J., and de Wildt D.J. Dietary vitamin E levels affect outcome of permanent focal cerebral ischemia in rats. Stroke 29 (1998) 1002-1005 discussion 1005-1006
226. van Haaften R.I., Haenen G.R., Evelo C.T., and Bast A. Tocotrienols inhibit human glutathione S-transferase P1-1. IUBMB Life 54 (2002) 81-84
227. Venkatesh T.V., Karunanandaa B., Free D.L., Rottnek J.M., Baszis S.R., and Valentin H.E. Identification and characterization of an Arabidopsis homogentisate phytyltransferase paralog. Planta 223 (2006) 1134-1144
228. Vraka P.S., Drouza C., Rikkou M.P., Odysseos A.D., and Keramidas A.D. Synthesis and study of the cancer cell growth inhibitory properties of α-, γ-tocopheryl and γ-tocotrienyl 2-phenylselenyl succinates. Bioorg. Med. Chem. 14 (2006) 2684-2696
229. Wada S., Satomi Y., Murakoshi M., Noguchi N., Yoshikawa T., and Nishino H. Tumor suppressive effects of tocotrienol in vivo and in vitro. Cancer Lett. 229 (2005) 181-191
230. Wagner K.H., Kamal-Eldin A., and Elmadfa I. Gamma-tocopherol-an underestimated vitamin?. Ann. Nutr. Metab. 48 (2004) 169-188
231. Wan Nazaimoon W.M., and Khalid B.A. Tocotrienols-rich diet decreases advanced glycosylation end-products in non-diabetic rats and improves glycemic control in streptozotocin-induced diabetic rats. Malays J. Pathol. 24 (2002) 77-82
232. Watkins T., Lenz P., Gapor A., Struck M., Tomeo A., and Bierenbaum M. γ-Tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets. Lipids 28 (1993) 1113-1118
233. Weber S.U., Thiele J.J., Han N., Luu C., Valacchi G., Weber S., and Packer L. Topical α-tocotrienol supplementation inhibits lipid peroxidation but fails to mitigate increased transepidermal water loss after benzoyl peroxide treatment of human skin. Free Radic. Biol. Med. 34 (2003) 170-176
234. Whittle K.J., Dunphy P.J., and Pennock J.F. The isolation and properties of δ-tocotrienol from Hevea latex. Biochem. J. 100 (1966) 138-145
235. Wie M.B., Koh J.Y., Won M.H., Lee J.C., Shin T.K., Moon C.J., Ha H.J., Park S.M., and Kim H.C. BAPTA/AM, an intracellular calcium chelator, induces delayed necrosis by lipoxygenase-mediated free radicals in mouse cortical cultures. Prog. Neuropsychopharmacol. Biol. Psychiatry 25 (2001) 1641-1659
236. Yamamoto S. Mammalian lipoxygenases: Molecular structures and functions. Biochim. Biophys. Acta 1128 (1992) 117-131
237. Yamasaki M., Nishida E., Nou S., Tachibana H., and Yamada K. Cytotoxity of the trans10,cis12 isomer of conjugated linoleic acid on rat hepatoma and its modulation by other fatty acids, tocopherol, and tocotrienol. In Vitro Cell. Dev. Biol. Anim. 41 (2005) 239-244
238. Yamashita K., Ikeda S., Iizuka Y., and Ikeda I. Effect of sesaminol on plasma and tissue α-tocopherol and α-tocotrienol concentrations in rats fed a vitamin E concentrate rich in tocotrienols. Lipids 37 (2002) 351-358
239. Yano Y., Satoh H., Fukumoto K., Kumadaki I., Ichikawa T., Yamada K., Hagiwara K., and Yano T. Induction of cytotoxicity in human lung adenocarcinoma cells by 6-O-carboxypropyl-α-tocotrienol, a redox-silent derivative of α-tocotrienol. Int. J. Cancer 115 (2005) 839-846
240. Yao Y., Clark C.M., Trojanowski J.Q., Lee V.M., and Pratico D. Elevation of 12/15 lipoxygenase products in AD and mild cognitive impairment. Ann. Neurol. 58 (2005) 623-626
241. Yap S.P., Yuen K.H., and Wong J.W. Pharmacokinetics and bioavailability of α-, γ- and δ-tocotrienols under different food status. J. Pharm. Pharmacol. 53 (2001) 67-71
242. Yap S.P., Yuen K.H., and Lim A.B. Influence of route of administration on the absorption and disposition of α-, γ- and delta-tocotrienols in rats. J. Pharm. Pharmacol. 55 (2003) 53-58
243. Yoneda T., Lowe C., Lee C.H., Gutierrez G., Niewolna M., Williams P.J., Izbicka E., Uehara Y., and Mundy G.R. Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo. J. Clin. Invest. 91 (1993) 2791-2795
244. Yoshida Y., Niki E., and Noguchi N. Comparative study on the action of tocopherols and tocotrienols as antioxidant: Chemical and physical effects. Chem. Phys. Lipids 123 (2003) 63-75
245. Yoshida Y., Itoh N., Hayakawa M., Piga R., Cynshi O., Jishage K., and Niki E. Lipid peroxidation induced by carbon tetrachloride and its inhibition by antioxidant as evaluated by an oxidative stress marker, HODE. Toxicol. Appl. Pharmacol. 208 (2005) 87-97
246. Yu F.L., Gapor A., and Bender W. Evidence for the preventive effect of the polyunsaturated phytol side chain in tocotrienols on 17β-estradiol epoxidation. Cancer Detect. Prev. 29 (2005) 383-388
247. Yu S.G., Thomas A.M., Gapor A., Tan B., Qureshi N., and Qureshi A.A. Dose-response impact of various tocotrienols on serum lipid parameters in 5-week-old female chickens. Lipids 41 (2006) 453-461
248. Yu W., Simmons-Menchaca M., Gapor A., Sanders B.G., and Kline K. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr. Cancer 33 (1999) 26-32
249. Zhou C., Tabb M.M., Sadatrafiei A., Grun F., and Blumberg B. Tocotrienols activate the steroid and xenobiotic receptor, SXR, and selectively regulate expression of its target genes. Drug Metab. Dispos. 32 (2004) 1075-1082
250. Zingg J.M., and Azzi A. Non-antioxidant activities of vitamin E. Curr. Med. Chem. 11 (2004) 1113-1133